Burning Rock Biotech (BNR) Change in Cash (2019 - 2026)

Burning Rock Biotech (BNR) has reported Change in Cash for 8 consecutive years, with -$4.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash fell 37.57% year-over-year to -$4.7 million; the TTM figure through Mar 2026 stood at -$10.4 million (up 53.42% YoY), while the FY2025 annual figure was -$5.9 million, up 53.93% from the prior year.
• Change in Cash came in at -$4.7 million for Q1 2026 at Burning Rock Biotech, down from $2.0 million in the prior quarter.
• The five-year high for Change in Cash was $3.3 million in Q4 2024, with the low at -$74.5 million in Q4 2022.
• Average Change in Cash over 5 years is -$13.0 million, with a median of -$9.4 million recorded in 2025.
• Across the five-year window, Change in Cash sank 190.44% in 2022 and soared 208.04% in 2024, its largest moves.
• Year by year, Change in Cash stood at -$74.5 million in 2022, then surged by 95.93% to -$3.0 million in 2023, then jumped by 208.04% to $3.3 million in 2024, then sank by 38.42% to $2.0 million in 2025, then tumbled by 332.46% to -$4.7 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$4.7 million, $2.0 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.